Neurofeedback Rehabilitation Reduces Anxiety in Methamphetamine Abusers

Roghieh Nooripour, Sverker Sikström, Nikzad Ghanbari, Simin Hosseinian, Peyman Hassani-Abharian, Hossein Ilanloo

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review


Addictive disorders are characterized by cognitive, behavioral, and neurological impairments caused by dysregulations of brain structure that can extend well beyond early withdrawal in the months and years of recovery. The present study aimed to examine the efficacy of neurofeedback rehabilitation on anxiety in methamphetamine abusers. The sample consisted of 14 male methamphetamine drug addicts who were randomly assigned to an experimental group (n = 7) and a control group (n = 7). Participants were assessed for Axis I disorders (SCID) and the Beck Anxiety Inventory (BAI). Mixed repeated ANOVA, independent t-tests, and chi-square were used for data analysis. The experimental group received 18 sessions of neurofeedback rehabilitation and standard psychological interventions treatment as usual, while the control group received only standard interventions. Results showed that neurofeedback significantly reduced anxiety in methamphetamine abusers at posttreatment and during a one-month follow-up. Along with other psychological interventions, neurofeedback rehabilitation is recommended for methamphetamine abusers.
Sidor (från-till)128–136
StatusPublished - 2021

Ämnesklassifikation (UKÄ)

  • Psykologi
  • Neurovetenskaper

Citera det här